We’re on a mission to transform care for people with severe, treatment-resistant psychiatric conditions through a new era of precision and personalization, powered by our implantable brain computer interface for emotion modulation.
Millions of patients with mental illness live trapped in dysfunctional emotional patterns that resist traditional treatments. PTSD is among the most debilitating psychiatric conditions, affecting 13M+ Americans, with 1.7M facing severe, treatment-resistant forms. While medications and therapy aim to manage symptoms, none can directly modulate the circuits where emotional dysfunction lives.
Nuri has developed the first emotion brain-computer interface (eBCI) for psychiatry that detects, decodes, and recalibrates trauma responses at the source.
Our implantable platform detects and decodes dysfunctional emotional circuits and delivers real-time, closed-loop neuromodulation through Deep Brain Recoding (DBR). By personalizing protocols to each patient’s neural signature and retraining emotional patterns using native learning mechanisms and adaptive stimulation, we offer a new path for treatment-resistant conditions, beginning with PTSD and expanding across psychiatric indications.
